NewslettersPancreatic Cell NewsGemcitabine and ATR Inhibitors Synergize to Kill PDAC Cells by Blocking DNA Damage ResponseBy Noshin Noorjahan - January 28, 2025017Investigators phenotypically screened 13 human PDAC cell lines against gemcitabine in combination with 146 clinical inhibitors and observed strong synergy for the ATR kinase inhibitor elimusertib in most cell lines.[Molecular Systems Biology]Full ArticleGraphical Abstract